REC formed bullish candlestick pattern on the daily charts with above average volumes. The 50-day EMA (exponential moving average placed at Rs 445) is crucial to watch in the coming session.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2515 in its research report dated January 31, 2024.